In addition, type-1 gene mutations (FLT3, PTPN11, NRAS NPM1, IDH1, IDH2, and WT1) were acquired during MDS progression to AML and are considered to be associated with faster leukemic transformation. This evidence concerns the gene FLT3 and acute myeloid leukemia.